SCHEMBL10047320

SCHEMBL10047320

Cc1ccc(S(=O)(=O)N=Cc2ccccc2F)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.52
ALDH1A1 P00352 6/20 0.49
GAA P10253 2/20 0.49
LMNA P02545 2/20 0.49
NFE2L2 Q16236 1/20 0.46
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
RECQL P46063 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.41
SPHK2 Q9NRA0 1/20 0.41
SPHK1 Q9NYA1 1/20 0.41
MMP2 P08253 1/20 0.41
CYP2C19 P33261 2/20 0.40
CYP2C9 P11712 1/20 0.40
F2 P00734 1/20 0.40
PRSS1 P07477 1/20 0.40
PRSS2 P07478 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10072996 1.00 POLB (0.52) POLBALDH1A1GAALMNANFE2L2
SCHEMBL5746398 0.84 POLB (0.55) POLBALDH1A1GAALMNAMAPK1
SCHEMBL5746395 0.84 POLB (0.55) POLBALDH1A1GAALMNAMAPK1
SCHEMBL18343542 0.81 POLB (0.52) POLBALDH1A1GAALMNAMAPK1
SCHEMBL31556700 0.81 POLB (0.52) POLBALDH1A1GAALMNAMAPK1
SCHEMBL18343544 0.81 POLB (0.52) POLBALDH1A1GAALMNAMAPK1
SCHEMBL10047322 0.79 POLB (0.50) POLBALDH1A1GAALMNACA1
SCHEMBL12444215 0.79 POLB (0.50) POLBALDH1A1GAALMNACA1
SCHEMBL29904955 0.78 GAA (0.78) POLBALDH1A1GAALMNARECQL
SCHEMBL29524908 0.78 ALDH1A1 (0.52) POLBALDH1A1GAALMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093274-B2 Inhibitors of protein prenyltransferases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-01-10 US disclosed
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES GGT1, FNTA, FNTB POLB 2318/4885ALDH1A1 1074/4885GAA 436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.